cp wire

CP Wire Articles

  • At one site, the surgery rate was reduced by more than 50%
  • Veracyte claims to have removed an estimated $800 million in surgery costs from the healthcare system


... read more

Mon, 10/8/18 - 10:08 am
admin
Uppsala, October 8, 2018. Lobsor Pharmaceuticals AB, a privately held Swedish company based in Uppsala today announced that Lecigon®, a new therapeutic system for symptomatic treatment... read more
Mon, 10/8/18 - 10:08 am
admin
  • 10 of 12 patients achieved treatment success
  • AB-SA01 was well tolerated with no adverse events attributable to AB-SA01
  • Initial gene expression data indicate that... read more
Mon, 10/8/18 - 09:49 am
admin
  • Thyroid cancer is the most rapidly increasing cancer diagnosis in the US with incidence tripling over the last 30 years
  • Cabometyx is approved for renal cell carcinoma and... read more
Mon, 10/8/18 - 09:25 am
admin
  • The company currently markets Natesto, the only FDA-approved nasal formulation of testosterone for men with hypogonadism (low testosterone, or "Low T")
  • Aytu also recently acquired... read more
Fri, 10/5/18 - 10:24 am
admin
  • Muscle funtion improved in 17 of 19 patients at month 12
  • Treatment with AT-GAA resulted in persistent and durable reductions in key biomarkers of muscle damage across all patient... read more
Fri, 10/5/18 - 09:46 am
admin
  • LentiGlobin has Orphan Drug status in Europe and the US
  • It has also been granted an accelerated assessment in Europe and Breakthrough Therapy designation in the US
  • ... read more
Fri, 10/5/18 - 09:18 am
admin

Vaxart Stock is up over 165% after after the biotechnology company announced results from a phase 2 trial that its oral flu vaccine performed better than Sanofi's Fluzone.

"These latest... read more

Thu, 10/4/18 - 09:57 am
admin
  • SNX-5422 has been granted Orphan Drug Status for neuroendocrine tumors by the FDA
  • SNX-5422 is an orally active Hsp90 inhibitor that has provided durable clinical responses in open... read more
Thu, 10/4/18 - 09:28 am
admin
  • Zimura also being studied in wet AMD,  idiopathic polypoidal choroidal vasculopathy, and  Stargardt disease
  • Initial Top-line Zimura Geographic Atrophy Data Expected in the Fourth... read more
Thu, 10/4/18 - 09:17 am
admin
  • During 8 month visit 57% of infants showed improvement during time when most with Type 1 SMA show no improvement or decline
  • Risdiplam is delivered orally
  • Risdiplam is being... read more
Wed, 10/3/18 - 09:24 am
admin


GO Therapeutics, Inc. (GO) announced on 10/2/18 that it has entered into a license agreement with F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc. (Roche). Under the terms of the agreement... read more

Tue, 10/2/18 - 09:58 am
admin
  • Rubraca previously received Breakthrough designation for the monotherapy treatment of certain advanced ovarian cancer patients
  • Rubraca is indicated as monotherapy for the treatment... read more
Tue, 10/2/18 - 09:49 am
admin


Rebiotix Inc., part of the Ferring Pharmaceuticals Group, announced on 10/1/18 that data new from their Microbiota Restoration Therapy™ (MRT) drug... read more

Mon, 10/1/18 - 11:29 pm
admin
  • ADMA received a CRL in July of 2016
  • The Company was able to resubmit RI-002’s BLA as a direct result of the recent improvement in compliance status for the Company’s Boca Raton, FL... read more
Mon, 10/1/18 - 10:00 am
admin
  • Results from the trial demonstrated that combination treatment with Adcetris plus CHP was superior to the control arm for progression free survival (PFS)
  • All other key secondary... read more
Mon, 10/1/18 - 09:28 am
admin


Five Prime Therapeutics, Inc. (Nasdaq: FPRX) and Zai Lab Limited (Nasdaq: ZLAB) announced on 10/1/18 dosing of the first patient in the Phase 3 FIGHT pivotal trial of bemarituzumab (FPA144),... read more

Mon, 10/1/18 - 09:07 am
admin
  • KSQ raised $76 million in October of 2017
  • The company has 14 candidates in pre-clinical development


KSQ Therapeutics announced today that the company has secured an... read more

Fri, 09/28/18 - 11:53 am
admin
  • Patisiran is approved in the US for hATTR
  • It has orphan drug status in the US and Japan
  • Patisiran is elegible for priority review in Japan


Alnylam... read more

Fri, 09/28/18 - 09:28 am
admin

Pages

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.